Security Alert

Beware of fraudulent messages impersonating amana.

We have been made aware of fraudulent emails, messages, and job offers circulating online from individuals falsely claiming to represent amana.

These scams may promise investment opportunities, employment, or financial rewards while requesting personal information, payments, or account details.

Please note that the only official amana website is
www.amana.app

Please also be aware of the following fraudulent domains impersonating amana:

amanacapital961
amana.live
getamana.com
client.amana-trade.com
amanatrade.net
amana-capital.net
amaanahcapitall.com

Deposit $200 to get a $100 trading bonus.

Use the promo code AMANAWEB.

Sign up now.*T&Cs Apply.

Terms & Conditions

  1. Offer valid for new users signing up on amana.
  2. How to Qualify for $100 Trading Bonus:
    • Sign up via the website.
    • Complete onboarding by providing the required details.
    • Enter promo code AMANAWEB at the final step.
    • Deposit $100 or more before your first trade.
    • Make your first trade.
  3. Once all steps are completed, you’ll receive a $100 non-withdrawable trading bonus.
  4. Bonuses are credited during the first week of every month.
  5. The bonus can only be used for trading and cannot be withdrawn.
  6. The campaign is exclusive to selected amana customers.
  7. amana reserves the right to cancel bonuses in cases of suspected fraud.
XAIR icon

XAIR

2.56 USD

-7.36%

Today

-12.30%

1D

Market is closed

Sun

Closed

Mon

4:30 PM ~ 10:59 PM

Tue

4:30 PM ~ 10:59 PM

Wed

4:30 PM ~ 10:59 PM

Thu

4:30 PM ~ 10:59 PM

Fri

4:30 PM ~ 10:59 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Beyond Air

Currency

USD

Market Cap

3.86M

Avg Daily Volume

216.76K

52 Week High

53.2 USD

52 Week Low

2.05 USD

Trading Hours

See hours

Business Summary

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Top News

Beyond.Air

-0.47%

Beyond Air expects revenue of $2.3M for quarter ended September 30

tradingview.com

3w ago

No Image

Beyond.Air

-0.47%

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

tradingview.com

3w ago

No Image

Beyond.Air

-0.47%

Beyond names Robert Goodman CEO employment agreement; Daniel Moorhead base salary raised

tradingview.com

1mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.